Sophia Genetics SA (SOPH)

Name: Sophia Genetics SA (SOPH) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Sophia Genetics SA (SOPH)

Stock Card

$8.14

$-0.78 (-8.74%)

As on 28-Aug-2026 16:00EDT

Market cap

$736 Mln

Revenue (TTM)

$86 Mln

P/E Ratio

P/B Ratio

8.5

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

Sophia Genetics SA (SOPH) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 8.06 High: 8.91

52 Week Range

Low: 3.10 High: 8.98

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-0.3
Debt to Equity

--
Book Value

$--
EPS

$--
Face value

--
Shares outstanding

85,127,825

5 Years Aggregate

CFO

$-240.02 Mln

EBITDA

$-283.65 Mln

Net Profit

$-313.24 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Sophia Genetics SA (SOPH)	74.3	44.1	60.2	144.4	50.2	-15.6	--
BSE Sensex	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2023	2022
Sophia Genetics SA (SOPH)	52.1	128.6	-85.4
S&P Small-Cap 600	4.0	13.9	-17.4
BSE Sensex	9.1	18.7	4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Sophia Genetics SA (SOPH)

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic... modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom and a collaboration with AstraZeneca to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies. The company was incorporated in 2011 and is based in Rolle, Switzerland. Read more

Co-Founder, CEO & Director

Dr. Jurgi Camblong M.B.A., Ph.D.
Co-Founder, CEO & Director

Dr. Jurgi Camblong M.B.A., Ph.D.
Headquarters

Rolle
Website

https://www.sophiagenetics.com

FAQs for Sophia Genetics SA (SOPH)

What is the current share price of Sophia Genetics SA (SOPH) Today?

The share price of Sophia Genetics SA (SOPH) is $8.14 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Sophia Genetics SA (SOPH) has given a return of 50.25% in the last 3 years.

What is the current PB & PE ratio of Sophia Genetics SA (SOPH)?

Since, TTM earnings of Sophia Genetics SA (SOPH) is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-4.03	6.76
2024	-3.24	2.10
2023	-3.88	2.02
2022	-1.51	0.66
2021	-11.41	3.05

What is the 52 Week High and Low of Sophia Genetics SA (SOPH)?

The 52-week high and low of Sophia Genetics SA (SOPH) are Rs 8.98 and Rs 3.10 as of 30-Aug-2026.

What is the market cap of Sophia Genetics SA (SOPH)?

Sophia Genetics SA (SOPH) has a market capitalisation of $ 736 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Sophia Genetics SA (SOPH)?

Before investing in Sophia Genetics SA (SOPH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.